Academy of Nutritional Medicine - AONM -
June 3, 2020
Dr. Jodie Dashore presents the BioNexus Approach for autism spectrum disorders in a The British Association for Nutrition and Lifestyle Medicine (BANT) webinar for UK practitioners.
Dr. Jodie A. Dashore is an internationally recognized pioneering clinician, presenter, researcher, and clinical herbalist. She holds a PhD in integrative medicine, is a board-certified holistic health practitioner, board-certified in integrative pediatrics, Registered Herbalist with the American Herbalist Guild, a Lyme literate clinician, and a CIRS Shoemaker certified practitioner. Dr. Dashore is the founder and director of BioNexus Health Clinic and BioNexus Herbals & Apothecary, dedicated to plant-based all-natural treatment options for autism, Lyme disease, PANS, and mold/biotoxin illness.
"Her excellent, safely acquired results show us we all have much to learn from her."
— Ritchie C. Shoemaker, MD
The BioNexus Approach to Biotoxin Illness: A step-by-step guide to sustainable, plant-based treatment options For over a decade, Dr. Jodie A. Dashore, PhD, OTD, BCIP, HHP, CCH, RH (AHG) has shared her plant-based clinical experiences and taught her philosophies and methods to parents, patients, and practitioners around the world. A master herbalist, Dr. Dashore's clinic, BioNexus Health, provides all-natural treatment alternatives to patients in over 50 countries. For the first time, she reveals the process, methods, and herbal recommendations used as a part of her BioNexus Approach to biotoxin illness.
The BioNexus Approach to Biotoxin Illness focuses on the full 360 of recovering and maintaining optimal health after CIRS-Mold and/or CIRS-Lyme. Dr. Dashore's method includes a wide-range of proprietary herbal formulations, including BioNexus Herbals Formula 1 NSB, a plant-based alternative treatment for MARCoNS, endorsed by the CIRS provider panel of Surviving Mold. A MicrobiologyDX study showed Formula 1 NSB eradicated, "MARCoNS consistent with the requirement of the Dr. R. Shoemaker protocol for CIRS."